Research Triangle Park, NC – EpiCypher, Inc. announces the commercial licensing of ChIC (University of Geneva) and CUT&RUN / CUT&Tag (Fred Hutchinson Cancer Research Center) technologies. These breakthrough tools reflect EpiCypher’s growing influence and expertise in epigenetics, and expand our product portfolio to include ultra-sensitive / robust chromatin profiling reagents, kits and services. Of note, […]
Cambridge, United Kingdom – 22 July 2019 – Congenica, a digital health company enabling accelerated genomic data interpretation, today announced it has renamed its software platform Congenica® and expanded its capabilities to include CNV calling for exome and gene panel sequencing. The latest software version will continue to streamline and enhance genomic clinical interpretation and help to reduce […]
AMSBIO has introduced a new range of homogeneous proximity assays, critical enzymes and small molecule inhibitors to assess the chemical adaptor function of Proteolysis Targeting Chimeras (PROTACs). Targeted protein degradation using PROTACs is a new and promising therapeutic method in drug discovery. PROTACs have the ability to regulate protein degradation through targeted control of ubiquitin […]
XpressBio, a small business leader in Life Science Research products, has launched an ELISA assay that can quantitatively detect levels of the Cas9 protein in cell culture. XpressBio, a small business leader in Life Science Research products, has launched an ELISA assay that can quantitatively detect levels of the Cas9 protein in cell culture. Knowing […]
Paris Atos, a global leader in digital transformation, was selected by GCS AURAGEN[1] – to provide and orchestrate the high-performance computing infrastructure and storage of a new genomic pilot platform for high-flow sequencing calculation. This platform has been selected as part of the French national plan for Genomic Science (‘France Médecine Génomique 2025’[2]). Atos will manage […]
AMSBIO has introduced a new range of homogeneous proximity assays, critical enzymes and small molecule inhibitors to assess the chemical adaptor function of Proteolysis Targeting Chimeras (PROTACs). Targeted protein degradation using PROTACs is a new and promising therapeutic method in drug discovery. PROTACs have the ability to regulate protein degradation through targeted control of ubiquitin […]
Arbor Biosciences, a division of Chiral Technologies, Inc and worldwide leader in next generation sequencing (NGS) target enrichment, announces a partnership with Curio Genomics for bioinformatics analysis of the wheat genome. Arbor has an ongoing collaboration with the International Wheat Genome Sequencing Consortium (IWGSC), an international organization dedicated to developing a gold-standard reference genome for […]
DARMSTADT, GERMANY New framework simplifies and accelerates access to CRISPR intellectual property for research Merck, a leading science and technology company, and the Broad Institute of MIT and Harvard (Boston, Massachusetts) today announced an agreement to offer non-exclusive licenses to CRISPR intellectual property (IP) under their respective control for use in commercial research and product […]
Automated volume reduction increases precision and accuracy in rare cell workflows Bologna, Italy and Huntingdon Valley, Pa. — Menarini Silicon Biosystems, the pioneer of liquid biopsy and rare cell technologies, announced that it will launch the new VRNxT™, a volume reduction instrument optimized to remove manual sample volume reduction steps in cellular biology workflows. By standardizing […]
MINNEAPOLIS — Bio-Techne Corporation (NASDAQ: TECH) today announced the launch of a new 8-Plex cartridge format for the ProteinSimple™-branded Ella™ automated immunoassay platform. This new cartridge format analyzes 32 samples for eight distinct analytes, bringing higher multiplex capabilities to the Ella platform. The 32×8 cartridge for Ella enables users to build panels of up to eight […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
